Using novel Fn14 inhibitory antibodies to treat cardiac cachexia in cancer

Lead researcher

Dr Kate Murphy, Prof John Silke, Prof Gordon Lynch, Prof Leanne Delbridge

The University of Melbourne

Years funded

This project tests the therapeutic potential of novel antibodies for reducing the heart failure associated with many cancers and chemotherapeutics. The results will lead to better treatment approaches and improved health outcomes for cancer patients.

Funding Body

Cancer Council Research Grant


$72,644 in 2017, $95,137 in 2018 and $95,137 in 2019